{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:10:35Z","timestamp":1789683035715,"version":"4.0.1"},"reference-count":402,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bjid.2026.105946","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:15:24Z","timestamp":1784603724000},"page":"105946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-8491","authenticated-orcid":false,"given":"Arnaldo L.","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-8265","authenticated-orcid":false,"given":"Marcello M.C.","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7037-3425","authenticated-orcid":false,"given":"Fabianne","family":"Carlesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-3833","authenticated-orcid":false,"given":"Diego R.","family":"Falci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-6680","authenticated-orcid":false,"given":"Marcia","family":"Garnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4946-911X","authenticated-orcid":false,"given":"Daniel W.C.L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-2418","authenticated-orcid":false,"given":"Flavio","family":"Queiroz-Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-5395","authenticated-orcid":false,"given":"Alessandro C.","family":"Pasqualotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2026.105946_bib0001","series-title":"WHO fungal priority pathogens list to guide research","year":"2022"},{"key":"10.1016\/j.bjid.2026.105946_bib0002","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","article-title":"Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer","volume":"17","author":"Colombo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0003","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/QCO.0000000000000411","article-title":"Emerging multidrug-resistant Candida species","volume":"30","author":"Colombo","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0004","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s13054-023-04673-6","article-title":"Critical appraisal beyond clinical guidelines for intraabdominal candidiasis","volume":"27","author":"Maseda","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/jof11050362","article-title":"Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review","volume":"11","author":"Pais","year":"2025","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0006","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0007","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.idc.2024.11.007","article-title":"Invasive Candidiasis","volume":"39","author":"Schroeder","year":"2025","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bjid.2026.105946_bib0009","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/cid\/ciac004","article-title":"Attributable Mortality of Candida Bloodstream Infections in the Modern Era: A Propensity Score Analysis","volume":"75","author":"Mazi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02041-24","article-title":"Name changes for fungi of medical importance, 2022-2024","volume":"63","author":"Borman","year":"2025","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0011","doi-asserted-by":"crossref","first-page":"ofac559","DOI":"10.1093\/ofid\/ofac559","article-title":"Fungal Nomenclature: Managing Change is the Name of the Game","volume":"10","author":"Kidd","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0013","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2020.11.006","article-title":"Clinical and epidemiological aspects of Candidemia in eight medical centers in the state of Parana, Brazil: Parana Candidemia Network","volume":"25","author":"de Oliveira","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0015","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.3855\/jidc.19091","article-title":"Epidemiology of invasive candidiasis before and during the COVID-19 pandemic at a hospital in southeastern Brazil","volume":"18","author":"Gieburowski","year":"2024","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.bjid.2026.105946_bib0016","doi-asserted-by":"crossref","first-page":"ofad358","DOI":"10.1093\/ofid\/ofad358","article-title":"Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis","volume":"10","author":"Colaneri","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0017","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/jof6040286","article-title":"Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?","volume":"6","author":"Riche","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0018","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis","volume":"161","author":"Thomas-R\u00fcddel","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.bjid.2026.105946_bib0019","article-title":"Prognostic factors of Candida spp. bloodstream infection in adults: A nine-year retrospective cohort study across tertiary hospitals in Brazil and Spain","volume":"6","author":"Agnelli","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.bjid.2026.105946_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/jof10040268","article-title":"Epidemiological Assessment and Risk Factors for Mortality of Bloodstream Infections by Candida sp. and the Impact of the COVID-19 Pandemic Era","volume":"10","author":"Araujo","year":"2024","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0021","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1016\/j.ijid.2012.02.005","article-title":"Epidemiology and predictors of a poor outcome in elderly patients with candidemia","volume":"16","author":"Guimar\u00e3es","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0022","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41564-021-00888-x","article-title":"Fungal taxonomy and sequence-based nomenclature","volume":"6","author":"L\u00fccking","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"Lass-Fl\u00f6rl","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bjid.2026.105946_bib0024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jof3020024","article-title":"Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers","volume":"3","author":"da Matta","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11046-024-00867-w","article-title":"Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries","volume":"189","author":"Hamburger","year":"2024","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0026","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/590191","article-title":"Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil","volume":"29","author":"Pasqualotto","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bjid.2019.05.004","article-title":"Brazil is so far free from Candida auris. Are we missing something?","volume":"23","author":"Pasqualotto","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0028","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/jof7030220","article-title":"Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit","volume":"7","author":"de Almeida","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0029","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/myc.12890","article-title":"Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilities","volume":"62","author":"Falci","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11046-020-00466-5","article-title":"Candidaemia Mortality Has not Changed Over the Last 2 Decades in Brazil","volume":"185","author":"Dalla Lana","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13669","article-title":"Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study","volume":"67","author":"Pe\u00e7anha-Pietrobom","year":"2024","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0032","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jof11020152","article-title":"Candidemia in ICU Patients: What Are the Real Game-Changers for Survival?","volume":"11","author":"de Almeida","year":"2025","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0033","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1128\/jcm.30.12.3239-3242.1992","article-title":"Value of extended agitation and subculture of BACTEC NR 660 aerobic resin blood culture bottles for clinical yeast isolates","volume":"30","author":"Prevost-Smith","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0034","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JCM.37.6.2024-2026.1999","article-title":"Times to detection of bacteria and yeasts in BACTEC 9240 blood culture bottles","volume":"37","author":"Reisner","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0035","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1128\/JCM.02048-13","article-title":"Evaluation of bactec mycosis IC\/F and Plus Aerobic\/F blood culture bottles for detection of Candida in the presence of antifungal agents","volume":"51","author":"K\u00f6ck","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0036","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diagmicrobio.2012.02.020","article-title":"Clinical comparison of the Bactec Mycosis IC\/F, BacT\/Alert FA, and BacT\/Alert FN blood culture vials for the detection of candidemia","volume":"73","author":"Ericson","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0037","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/JCM.42.2.773-777.2004","article-title":"Comparison of Mycosis IC\/F and plus Aerobic\/F media for diagnosis of fungemia by the bactec 9240 system","volume":"42","author":"Meyer","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0038","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10096-014-2218-4","article-title":"Evaluation of blood culture media for the detection of fungi","volume":"34","author":"Nawrot","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.riam.2024.06.001","article-title":"Experimental study of specific and nonspecific blood culture bottles for the diagnosis of candidemia","volume":"41","author":"Wilot","year":"2024","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2026.105946_bib0040","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0041","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/clinids\/5.1.35","article-title":"The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations","volume":"5","author":"Weinstein","year":"1983","journal-title":"Clin Infect Dis"},{"issue":"18 Suppl 7","key":"10.1016\/j.bjid.2026.105946_bib0042","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"51 Suppl 7","key":"10.1016\/j.bjid.2026.105946_bib0043","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imj.15589","article-title":"Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021","author":"Keighley","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.bjid.2026.105946_bib0044","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0045","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00598-23","article-title":"Detailed \u03b2-(1\u21923)-D-glucan and mannan antigen kinetics in patients with candidemia","volume":"61","author":"Tr\u00e4ger","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0046","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/JCM.02473-12","article-title":"Comparison of (1->3)-\u03b2-D-glucan, mannan\/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia","volume":"51","author":"Held","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0047","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive Candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0048","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0049","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QCO.0000000000000594","article-title":"Rapid diagnosis of invasive candidiasis: ready for prime-time?","volume":"32","author":"Clancy","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s43994-023-00049-2","article-title":"Candida diagnostic techniques: a review","volume":"9","author":"Arafa","year":"2023","journal-title":"JUmm Al-Qura Univ Appll Sci"},{"key":"10.1016\/j.bjid.2026.105946_bib0051","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2174\/1568026618666181025093146","article-title":"Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies","volume":"18","author":"Pitarch","year":"2018","journal-title":"CTMC"},{"key":"10.1016\/j.bjid.2026.105946_bib0052","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/jof6030101","article-title":"Molecular Methods for the Diagnosis of Invasive Candidiasis","volume":"6","author":"Camp","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0053","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02547-22","article-title":"Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections","volume":"11","author":"Cam\u00e9l\u00e9na","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bjid.2026.105946_bib0054","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/myc.13633","article-title":"Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI-TOF MS identification","volume":"66","author":"Taverna","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/mmy\/myaa049","article-title":"CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris","volume":"59","author":"Borman","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2026.105946_bib0056","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00974-24","article-title":"Allard C. Performance of common primary and chromogenic culture media for MALDI-TOF MS identification of clinically relevant yeasts","volume":"12","author":"L\u00e9vesque","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bjid.2026.105946_bib0057","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.00802-15","article-title":"Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy","volume":"53","author":"Posteraro","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4094932","article-title":"Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification","author":"Grant","year":"2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0059","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/microorganisms9061283","article-title":"MALDI-TOF MS in a Medical Mycology Laboratory: On Stage and Backstage","volume":"9","author":"Robert","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.bjid.2026.105946_bib0060","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s42770-025-01725-7","article-title":"Identification of rare Candida species isolated from various clinical specimens: Comparison of different methods","volume":"56","author":"Caklovica Kucukkaya","year":"2025","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0061","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ejhpharm-2017-001467","article-title":"Do we need to adopt antifungal stewardship programmes?","volume":"27","author":"Ioannidis","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.bjid.2026.105946_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.720609","article-title":"Can We Improve Antifungal Susceptibility Testing?","volume":"11","author":"Durand","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal Susceptibility Testing: Current Approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bjid.2026.105946_bib0064","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/jof8030309","article-title":"Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance","volume":"8","author":"Espinel-Ingroff","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/JCM.01840-06","article-title":"Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents","volume":"45","author":"Alexander","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0066","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11046-024-00867-w","article-title":"Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries","volume":"189","author":"Hamburger","year":"2024","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0067","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/jof4030110","article-title":"Susceptibility Testing of Fungi to Antifungal Drugs","volume":"4","author":"Sanguinetti","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0068","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cmi.2020.06.007","article-title":"How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)","volume":"26","author":"Arendrup","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0069","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11046-024-00861-2","article-title":"Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining Challenges","volume":"189","author":"Arendrup","year":"2024","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jof7010017","article-title":"Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections","volume":"7","author":"Lamoth","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0071","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.riam.2015.10.002","article-title":"High rate of Candida deep-seated infection in patients under chronic hemodialysis with extended central venous catheter use","volume":"33","author":"Ourives","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2026.105946_bib0072","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cid\/ciad064","article-title":"Prevalence of Ocular Candidiasis and Candida Endophthalmitis in Patients With Candidemia: A Systematic Review and Meta-Analysis","volume":"76","author":"Phongkhun","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0073","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2021.07.015","article-title":"American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis","volume":"129","author":"Breazzano","year":"2022","journal-title":"Ophthalmology."},{"key":"10.1016\/j.bjid.2026.105946_bib0074","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaophthalmol.2019.0733","article-title":"Utility of Ophthalmologic Screening for Patients With Candida Bloodstream Infections: A Systematic Review","volume":"137","author":"Breazzano","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.bjid.2026.105946_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.riam.2015.10.002","article-title":"High rate of Candida deep-seated infection in patients under chronic hemodialysis with extended central venous catheter use","volume":"33","author":"Ourives","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2026.105946_bib0077","doi-asserted-by":"crossref","first-page":"271","DOI":"10.22354\/in.v23i3.792","article-title":"Colombian consensus on the diagnosis, treatment, and prevention of Candida spp. disease in children and adults","volume":"23","author":"O\u00f1ate","year":"2019","journal-title":"Infectio"},{"key":"10.1016\/j.bjid.2026.105946_bib0078","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00019-23","article-title":"Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management","volume":"36","author":"Thompson","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bjid.2026.105946_bib0079","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10096-015-2384-z","article-title":"The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort","volume":"34","author":"Fern\u00e1ndez-Cruz","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/QCO.0000000000000684","article-title":"Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients","volume":"33","author":"Pe\u00e7anha-Pietrobom","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0081","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70032","article-title":"Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1- Year Mortality","volume":"68","author":"Vieceli","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0082","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjcard.2025.06.023","article-title":"Incidence and Predictors of Candida Endocarditis in Hospitalized Patients With Candidemia: Insights From the National Inpatient Sample (2016 to 2022)","volume":"254","author":"Meyahnwi","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0083","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.riam.2015.10.002","article-title":"High rate of Candida deep-seated infection in patients under chronic hemodialysis with extended central venous catheter use","volume":"33","author":"Ourives","year":"2016","journal-title":"Rev Iberoam Micol"},{"issue":"25","key":"10.1016\/j.bjid.2026.105946_bib0084","first-page":"00290","article-title":"ESCMID Fungal Infection Study Group (EFISG) Candida endocarditis: current perspectives on diagnosis and therapy","volume":"S1198-743X","author":"Ben-Ami","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myz104","article-title":"Risk factors predicting Candida infective endocarditis in patients with candidemia","volume":"58","author":"Foong","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2026.105946_bib0086","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/myc.13200","article-title":"Candida spp. infective endocarditis: Characteristics and outcomes of twenty patients with a focus on injection drug use as a predisposing risk factor","volume":"64","author":"Morelli","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0087","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0088","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1745-6215-14-399","article-title":"EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial","volume":"14","author":"Timsit","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.bjid.2026.105946_bib0089","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0090","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2024.104495","article-title":"Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit","volume":"29","author":"Cort\u00e9s","year":"2025","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0092","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkw188","article-title":"Discontinuation of empirical antifungal therapy in ICU patients using 1,3-\u03b2-d-glucan","volume":"71","author":"Nucci","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0093","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.diagmicrobio.2019.04.016","article-title":"T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit","volume":"95","author":"Gill","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116107","article-title":"Utility of incorporation of beta-D-glucan and T2Candida testing for diagnosis and treatment of candidemia","volume":"108","author":"Zacharioudakis","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13054-020-03265-y","article-title":"(1,3)-\u03b2-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial","volume":"24","author":"De Pascale","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0096","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","article-title":"Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial","volume":"43","author":"Rouz\u00e9","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0097","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042282","article-title":"\u03b2-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study","volume":"7","author":"Hanson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2026.105946_bib0098","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1471-2334-14-385","article-title":"Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU","volume":"14","author":"Bruy\u00e8re","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0099","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/jac\/dkad256","article-title":"Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of Candidaemia: results from a Phase 2 trial","volume":"78","author":"Pappas","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0100","first-page":"179","article-title":"Recommendations for the management of candidemia in adults in Latin America. Latin America Invasive Mycosis Network","volume":"30","author":"Nucci","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2026.105946_bib0101","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/jac\/dkv241","article-title":"Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment","volume":"70","author":"Mart\u00ednez-Jim\u00e9nez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0102","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0103","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0104","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2015.07.019","article-title":"Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes","volume":"492","author":"Briot","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bjid.2026.105946_bib0106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"Rezafungin versus caspofungin for treatment of Candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2026.105946_bib0107","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(23)00551-0","article-title":"Efficacy and safety of rezafungin and caspofungin in Candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials","volume":"24","author":"Thompson","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0108","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1093\/cid\/ciaa1380","article-title":"Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0109","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13054-024-05117-5","article-title":"Rezafungin versus caspofungin for patients with Candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials","volume":"28","author":"Honor\u00e9","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0110","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1093\/cid\/ciaa1380","article-title":"Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13054-024-05117-5","article-title":"Rezafungin versus caspofungin for patients with Candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials","volume":"28","author":"Honor\u00e9","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0112","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13054-024-05152-2","article-title":"Length of hospital and intensive care unit stay in patients with invasive candidiasis and\/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials","volume":"28","author":"Honor\u00e9","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0113","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/CCM.0000000000002867","article-title":"Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study","volume":"46","author":"Garnacho-Montero","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0114","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","article-title":"Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data","volume":"41","author":"Bailly","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0116","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/CCM.0000000000002867","article-title":"Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study","volume":"46","author":"Garnacho-Montero","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0117","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0118","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","article-title":"Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data","volume":"41","author":"Bailly","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0122","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","article-title":"Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era","volume":"38","author":"Agnelli","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0119","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jinf.2017.05.019","article-title":"Clinical characteristics and risk factors for mortality in adult patients with persistent candidemia","volume":"75","author":"Kang","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0121","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/myc.13085","article-title":"Persistent vs non-persistent Candidaemia in adult patients in 2007-2016: A retrospective cohort study","volume":"63","author":"Ala-Houhala","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106586","article-title":"Persistent candidemia caused by different Candida species: Data from a multicenter contemporary cohort","volume":"91","author":"Tiseo","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0124","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/microorganisms11040928","article-title":"Clinical Features and Outcomes of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-Up Blood Cultures","volume":"11","author":"Kitaya","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.bjid.2026.105946_bib0125","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10096-015-2384-z","article-title":"The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort","volume":"34","author":"Fern\u00e1ndez-Cruz","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0126","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0035-1562891","article-title":"Complications of Candidemia in ICU Patients: Endophthalmitis","volume":"36","author":"Kauffman","year":"2015","journal-title":"Osteomyelitis, Endocarditis. Semin Respir Crit Care Med."},{"key":"10.1016\/j.bjid.2026.105946_bib0127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-025-05527-z","article-title":"Screening, prevalence, and risk factors for secondary localization during candidemia in intensive care unit patients: the French CandidICU multicenter study","volume":"29","author":"Reizine","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-025-05527-z","article-title":"Screening, prevalence, and risk factors for secondary localization during candidemia in intensive care unit patients: the French CandidICU multicenter study","volume":"29","author":"Reizine","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0129","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11046-023-00776-4","article-title":"Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study","volume":"188","author":"Egger","year":"2023","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(22)00872-6","article-title":"Guideline adherence and survival of patients with Candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study","volume":"23","author":"Hoenigl","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s15010-012-0369-8","article-title":"Duration of treatment for candidemia and risk for late-onset ocular candidiasis","volume":"41","author":"Blennow","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2026.105946_bib0132","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10096-002-0854-6","article-title":"Duration of antifungal treatment and development of delayed complications in patients with Candidaemia","volume":"22","author":"Oude Lashof","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0134","doi-asserted-by":"crossref","first-page":"ofac656","DOI":"10.1093\/ofid\/ofac656","article-title":"Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?","volume":"10","author":"Vena","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0135","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13672","article-title":"Questioning the 14-day dogma in candidemia treatment duration","volume":"67","author":"Salmanton-Garc\u00eda","year":"2024","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0136","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/587101","article-title":"When primary antifungal therapy fails","volume":"46","author":"Nucci","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10840-020-00706-0","article-title":"Candidemia in patients with cardiovascular implantable electronic devices","volume":"60","author":"Nakamura","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.01.014","article-title":"Impact of fluconazole susceptibility on the outcome of patients with Candidaemia: data from a population-based surveillance","volume":"23","author":"Fern\u00e1ndez-Ruiz","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.108046","article-title":"Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of Candida bloodstream infections: a retrospective multicenter cohort study","volume":"160","author":"Bavaro","year":"2025","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myz104","article-title":"Risk factors predicting Candida infective endocarditis in patients with candidemia","volume":"58","author":"Foong","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2026.105946_bib0141","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1634\/theoncologist.2017-0019","article-title":"Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?","volume":"22","author":"van Prehn","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.bjid.2026.105946_bib0142","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1179\/joc.2007.19.3.335","article-title":"Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines","volume":"19","author":"Pacini","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0143","article-title":"Central venous catheter (CVC) removal for patients of all ages with Candidaemia","volume":"7","author":"Janum","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2026.105946_bib0144","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1128\/AAC.49.8.3171-3177.2005","article-title":"Fluconazole MIC and the fluconazole dose\/MIC ratio correlate with therapeutic response among patients with candidemia","volume":"49","author":"Clancy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0145","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10096-019-03611-1","article-title":"The association between fluconazole dose and MIC with mortality and persistence in candidemia","volume":"38","author":"Ghanem-Zoubi","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0076","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0146","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01582-16","article-title":"Low Caspofungin Exposure in Patients in Intensive Care Units","volume":"61","author":"van der Elst","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0147","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/AAC.01607-13","article-title":"Low but sufficient anidulafungin exposure in critically ill patients","volume":"58","author":"van Wanrooy","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0148","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jac\/dkae415","article-title":"The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics","volume":"80","author":"Andes","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0149","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13054-018-2019-8","article-title":"Population pharmacokinetics\/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients","volume":"22","author":"Maseda","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/QCO.0000000000001063","article-title":"Reassessment of the role of combination antifungal therapy in the current era","volume":"37","author":"Neoh","year":"2024","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0151","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jac\/dkh434","article-title":"Combinations of antifungal agents in therapy\u2013what value are they?","volume":"54","author":"Cuenca-Estrella","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0152","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ijid.2022.07.056","article-title":"In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method","volume":"122","author":"Yang","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0153","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0154","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10096-005-0024-8","article-title":"International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia","volume":"24","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0155","first-page":"24","article-title":"Combination antifungal therapy: where are we now, and where are we going?","volume":"18","author":"Marr","year":"2004","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.bjid.2026.105946_bib0156","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/pds.1365","article-title":"Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines","volume":"16","author":"Garey","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bjid.2026.105946_bib0157","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00984-20","article-title":"Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing","volume":"64","author":"Muilwijk","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0158","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1517\/17425255.2011.615309","article-title":"Pharmacokinetic evaluation of fluconazole in critically ill patients","volume":"7","author":"Sinnollareddy","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bjid.2026.105946_bib0159","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0160","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00820-23","article-title":"Optimizing anidulafungin exposure across a wide adult body size range","volume":"67","author":"Hall","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176576","article-title":"Candidemia in the elderly: What does it change?","volume":"12","author":"Barchiesi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2026.105946_bib0162","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.riam.2011.06.004","article-title":"[Invasive candidiasis in liver transplant recipient: early rescue antifungal treatment]","volume":"28","author":"Pozo-Laderas","year":"2011","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2026.105946_bib0163","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ajhp\/zxz054","article-title":"Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy","volume":"76","author":"Branick","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bjid.2026.105946_bib0164","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/phar.2348","article-title":"Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation","volume":"40","author":"Zhao","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bjid.2026.105946_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107078","article-title":"The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review","volume":"63","author":"Jendoubi","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2026.105946_bib0166","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40262-024-01461-5","article-title":"Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations","volume":"64","author":"Albanell-Fern\u00e1ndez","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bjid.2026.105946_bib0167","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3934\/microbiol.2023025","article-title":"Biofilm: The invisible culprit in catheter-induced candidemia","volume":"9","author":"Wijaya","year":"2023","journal-title":"AIMS Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0168","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/myc.13179","article-title":"Impact of biofilm production by Candida species and antifungal therapy on mortality of patients with candidemia","volume":"63","author":"Lee","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0169","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections","volume":"68","author":"Garnacho-Montero","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0170","article-title":"Central venous catheter (CVC) removal for patients of all ages with Candidaemia","volume":"7","author":"Janum","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2026.105946_bib0171","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections","volume":"68","author":"Garnacho-Montero","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0172","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhin.2019.08.018","article-title":"Clinical impacts of delayed central venous catheter removal according to the severity of comorbidities in patients with Candidaemia","volume":"103","author":"Lee","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0173","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bjid.2018.10.278","article-title":"Time of catheter removal in candidemia and mortality","volume":"22","author":"Nucci","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0174","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1469-0691.2007.01758.x","article-title":"Impact of early central venous catheter removal on outcome in patients with Candidaemia","volume":"13","author":"Rodriguez","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jinf.2017.05.019","article-title":"Clinical characteristics and risk factors for mortality in adult patients with persistent candidemia","volume":"75","author":"Kang","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0176","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0177","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s10096-019-03578-z","article-title":"Central venous catheter unrelated candidemia influences the outcome of infection in patients with solid tumors","volume":"38","author":"Orsetti","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0178","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0179","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2007.01843.x","article-title":"The importance of central venous catheter removal in patients with Candidaemia: time to rethink our practice?","volume":"14","author":"Pasqualotto","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jinf.2008.12.008","article-title":"Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome","volume":"58","author":"Liu","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0181","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365548.2010.524657","article-title":"Factors prompting early central venous catheter removal from cancer patients with Candidaemia","volume":"43","author":"Velasco","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0182","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s15010-020-01393-9","article-title":"Epidemiology of candidemia and impact of infectious disease consultation on survival and care","volume":"48","author":"Mohr","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2026.105946_bib0183","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/cid\/ciy849","article-title":"Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With Candidemia","volume":"68","author":"Lee","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0184","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215996","article-title":"The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years","volume":"14","author":"Ishikane","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2026.105946_bib0185","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S1473-3099(19)30405-0","article-title":"Effect of infectious disease consultation on mortality and treatment of patients with Candida bloodstream infections: a retrospective, cohort study","volume":"19","author":"Mejia-Chew","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0186","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.01.013","article-title":"Antifungal stewardship in a tertiary-care institution: a bedside intervention","volume":"21","author":"Valerio","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0187","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmi.2014.07.006","article-title":"Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation","volume":"21","author":"Farmakiotis","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0188","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S1473-3099(19)30405-0","article-title":"Effect of infectious disease consultation on mortality and treatment of patients with Candida bloodstream infections: a retrospective, cohort study","volume":"19","author":"Mejia-Chew","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0189","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/0037-8682-0057-2013","article-title":"Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians","volume":"46","author":"Schultz","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bjid.2026.105946_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmi.2014.07.006","article-title":"Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation","volume":"21","author":"Farmakiotis","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0191","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0192","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0193","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-013-3134-2","article-title":"Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis","volume":"39","author":"Montravers","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0194","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0195","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1089\/sur.2023.149","article-title":"Identification of Risk Factors for Intra-Abdominal Candidiasis","volume":"24","author":"Habighorst","year":"2023","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.bjid.2026.105946_bib0196","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00003246-200203000-00008","article-title":"NORGAS Group and the Norwegian Yeast Study Group Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations","volume":"30","author":"Sandven","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0197","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2009.202","article-title":"Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients","volume":"76","author":"Miles","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.bjid.2026.105946_bib0198","first-page":"283","article-title":"Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia","volume":"17","author":"Colombo","year":"2013","journal-title":"Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis."},{"key":"10.1016\/j.bjid.2026.105946_bib0199","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13054-023-04742-w","article-title":"Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis","volume":"27","author":"Novy","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0200","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10096-019-03617-9","article-title":"Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies","volume":"38","author":"Sganga","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0201","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmi.2016.06.005","article-title":"Predictors of choice of initial antifungal treatment in intraabdominal candidiasis","volume":"22","author":"Lagunes","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0202","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02565-20","article-title":"Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients","volume":"65","author":"Welte","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0203","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02307-20","article-title":"Prospective Cohort Study of Micafungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-abdominal Infections","volume":"65","author":"Garbez","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0204","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1093\/cid\/ciaa1380","article-title":"Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0205","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01009-17","article-title":"Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0206","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for Candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2026.105946_bib0207","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01721-22","article-title":"Pharmacokinetics of Voriconazole in Peritoneal Fluid of Critically Ill Patients","volume":"67","author":"Lin","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0208","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/ajkd.2000.19833","article-title":"Factors predicting outcome of fungal peritonitis in peritoneal dialysis: Analysis of a 9-year experience of fungal peritonitis in a single center","volume":"36","author":"Wang","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.bjid.2026.105946_bib0209","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","article-title":"A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0210","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s15010-024-02222-z","article-title":"Role of source control in critically ill candidemic patients: a multicenter retrospective study","volume":"52","author":"Marangos","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2026.105946_bib0211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153247","article-title":"Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment","volume":"11","author":"Vergidis","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2026.105946_bib0212","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13807","article-title":"Intra-Abdominal Candidiasis in Cancer Patients: A 10-Year Experience in a Middle-Income Country","volume":"67","author":"De Almeida","year":"2024","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0213","doi-asserted-by":"crossref","DOI":"10.23736\/S0375-9393.17.11528-2","article-title":"Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICU","volume":"83","author":"Dimopoulos","year":"2017","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0214","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00268-020-05380-x","article-title":"Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis","volume":"44","author":"Yan","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.bjid.2026.105946_bib0215","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0216","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijid.2018.09.016","article-title":"Outcomes in patients with fungal endocarditis: A multicenter observational cohort study","volume":"77","author":"Siciliano","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0217","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","article-title":"A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis","volume":"48","author":"Betts","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0218","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1111\/j.1469-0691.2012.03764.x","article-title":"Diagnosis, management and outcome of Candida endocarditis","volume":"18","author":"Lefort","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0219","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cid\/cix913","article-title":"Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study","volume":"66","author":"Rivoisy","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0220","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/14787210.2017.1372749","article-title":"Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis","volume":"15","author":"Giuliano","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bjid.2026.105946_bib0221","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.04867-14","article-title":"Candida infective endocarditis: an observational cohort study with a focus on therapy","volume":"59","author":"Arnold","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0222","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10096-008-0466-x","article-title":"Candida infective endocarditis","volume":"27","author":"Baddley","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0223","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MD.0b013e3182259d38","article-title":"The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis","volume":"90","author":"Smego","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bjid.2026.105946_bib0224","doi-asserted-by":"crossref","first-page":"789","DOI":"10.21470\/1678-9741-2019-0159","article-title":"Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review","volume":"35","author":"Bezerra","year":"2020","journal-title":"Braz J Cardiovasc Surg"},{"key":"10.1016\/j.bjid.2026.105946_bib0225","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10096-007-0386-1","article-title":"Candida parapsilosis endocarditis: a comparative review of the literature","volume":"26","author":"Garzoni","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0226","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jinf.2004.10.016","article-title":"A meta-analysis of medical versus surgical therapy for Candida endocarditis","volume":"51","author":"Steinbach","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0227","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae042","article-title":"Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report","volume":"6","author":"Mori","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.bjid.2026.105946_bib0228","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00750-24","article-title":"Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy)","volume":"68","author":"Ponta","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0229","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis*","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s15010-018-1152-2","article-title":"Neuroinfections caused by fungi","volume":"46","author":"G\u00f3ralska","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2026.105946_bib0231","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00415-025-12954-z","article-title":"Clinical, diagnostic and therapeutic challenges in CNS fungal infections: a single-center retrospective data analysis","volume":"272","author":"Masouris","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.bjid.2026.105946_bib0299","unstructured":"Technical note GVIMS\/GGTES\/ANVISA No 02\/2022. n.d."},{"key":"10.1016\/j.bjid.2026.105946_bib0232","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bjid.2026.105946_bib0233","first-page":"711","article-title":"Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis","volume":"46","author":"Kretschmar","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bjid.2026.105946_bib0234","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0235","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01626-19","article-title":"Amphotericin B Penetrates into the Central Nervous System through Focal Disruption of the Blood-Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis","volume":"63","author":"Petraitis","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0236","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/513746","article-title":"Candidal Meningitis in HIV-Infected Patients: Analysis of 14 Cases","volume":"25","author":"Casado","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0237","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00365540310017573","article-title":"Clinical characteristics, treatment and prognostic factors of Candidal meningitis in a teaching hospital in Taiwan","volume":"36","author":"Chen","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0238","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/clinids\/6.6.791","article-title":"Combined Therapy with Amphotericin B and 5-Fluorocytosine for Candida Meningitis","volume":"6","author":"Smego","year":"1984","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0239","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00701-011-0990-9","article-title":"Candida infection of the central nervous system following neurosurgery: a 12-year review","volume":"153","author":"O\u2019Brien","year":"2011","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.bjid.2026.105946_bib0240","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1097\/MS9.0000000000002155","article-title":"Multiple brain abscesses in a neonate: a rare case report along with review of literature","volume":"86","author":"Mehta","year":"2024","journal-title":"Annals of Medicine & Surgery"},{"key":"10.1016\/j.bjid.2026.105946_bib0241","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2024.100519","article-title":"Candida dubliniensis meningitis in an immunocompetent patient: A case report and review of the literature","volume":"36","author":"Babici","year":"2024","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.bjid.2026.105946_bib0242","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/jof10090654","article-title":"Central Nervous System Fungal Diseases in Children with Malignancies: A 16-Year Study from the Infection Working Group of the Hellenic Society of Pediatric Hematology Oncology","volume":"10","author":"Petrikkos","year":"2024","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0243","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae743","article-title":"Successful Treatment of Candida auris Ventriculitis With Intravenous Liposomal Amphotericin B and Oral Flucytosine: A Case Report","volume":"12","author":"Kang","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0244","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.39.3.598","article-title":"Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B","volume":"39","author":"Sugar","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0245","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/AAC.43.12.2841","article-title":"Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans","volume":"43","author":"Louie","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0246","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s15010-019-01275-9","article-title":"In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid","volume":"47","author":"Al Jalali","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2026.105946_bib0247","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107379","article-title":"Monitoring of the cerebrospinal fluid voriconazole level in a patient with recurrent Candida meningitis after pituitary surgery","volume":"64","author":"Ucdal","year":"2024","journal-title":"Intern J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2026.105946_bib0248","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/02688697.2022.2054947","article-title":"Candida meningitis\/ventriculitis over a decade. Increased morbidity and length of stay a concern","volume":"37","author":"Kelly","year":"2023","journal-title":"British Journal of Neurosurgery"},{"key":"10.1016\/j.bjid.2026.105946_bib0249","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mmcr.2018.08.005","article-title":"Successful treatment of C. auris shunt infection with intraventricular caspofungin","volume":"22","author":"Singhal","year":"2018","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.bjid.2026.105946_bib0250","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0251","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00086-19","article-title":"Osteoarticular Mycoses","volume":"35","author":"Gamaletsou","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bjid.2026.105946_bib0252","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diagmicrobio.2012.02.004","article-title":"Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature","volume":"73","author":"Slenker","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0253","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10096-013-1939-0","article-title":"Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance\u00ae registry","volume":"33","author":"Neofytos","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0254","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00264-023-05989-2","article-title":"Candida spondylodiscitis: a systematic review and meta-analysis of seventy two studies","volume":"48","author":"Adelhoefer","year":"2024","journal-title":"International Orthopaedics (SICOT)"},{"key":"10.1016\/j.bjid.2026.105946_bib0255","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00586-016-4827-3","article-title":"Management of destructive Candida albicans spondylodiscitis of the cervical spine: a systematic analysis of literature illustrated by an unusual case","volume":"26","author":"Stolberg-Stolberg","year":"2017","journal-title":"Eur Spine J"},{"key":"10.1016\/j.bjid.2026.105946_bib0256","series-title":"The Funnel: From the Skull Base to the Sacrum","first-page":"231","article-title":"Vertebral Candidiasis, the State of the Art: A Systematic Literature Review","volume":"135","author":"Candura","year":"2023"},{"key":"10.1016\/j.bjid.2026.105946_bib0257","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/cid\/cis660","article-title":"Candida Osteomyelitis: Analysis of 207 Pediatric and Adult Cases (1970-2011)","volume":"55","author":"Gamaletsou","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0258","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1186\/s12891-024-07616-6","article-title":"The heavy burden and treatment challenges of fungal periprosthetic joint infection: a systematic review of 489 joints","volume":"25","author":"Shang","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bjid.2026.105946_bib0259","first-page":"5748","article-title":"Fungal periprosthetic joint infection of the hip: a systematic review","volume":"7","author":"Schoof","year":"2015","journal-title":"Orthop Rev (Pavia)"},{"key":"10.1016\/j.bjid.2026.105946_bib0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00264-019-04369-z","article-title":"Candida periprosthetic infection of the hip: a systematic review of surgical treatments and clinical outcomes","volume":"44","author":"Fusini","year":"2020","journal-title":"International Orthopaedics (SICOT)"},{"key":"10.1016\/j.bjid.2026.105946_bib0261","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00590-022-03224-z","article-title":"Candida periprosthetic infection of the knee: a systematic review of surgical treatments and clinical outcomes","volume":"33","author":"Fusini","year":"2022","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"10.1016\/j.bjid.2026.105946_bib0262","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/cid\/ciae395","article-title":"Prosthetic Joint Infections due to Candida Species: A Multicenter International Study","volume":"80","author":"Dinh","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0263","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13018-025-05565-x","article-title":"Evaluation and testing of polymethylmetacrylic (PMMA) bone cements with admixed Amphotericin B","volume":"20","author":"Frank","year":"2025","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.bjid.2026.105946_bib0264","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1186\/s12891-024-07616-6","article-title":"The heavy burden and treatment challenges of fungal periprosthetic joint infection: a systematic review of 489 joints","volume":"25","author":"Shang","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bjid.2026.105946_bib0265","first-page":"5748","article-title":"Fungal periprosthetic joint infection of the hip: a systematic review","volume":"7","author":"Schoof","year":"2015","journal-title":"Orthop Rev (Pavia)"},{"key":"10.1016\/j.bjid.2026.105946_bib0266","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jiac.2023.06.019","article-title":"Ocular candidiasis in a tertiary hospital in Japan: A 10-year single-center retrospective study","volume":"29","author":"Sano","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0267","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-021-00248-0","article-title":"Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia","volume":"11","author":"Sakai","year":"2021","journal-title":"J Ophthal Inflamm Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0268","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222356","article-title":"Risk factors and outcomes of patients with ocular involvement of candidemia","volume":"14","author":"Son","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bjid.2026.105946_bib0269","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/09273940802689396","article-title":"Vitrectomy for Endogenous Fungal Endophthalmitis","volume":"17","author":"Shen","year":"2009","journal-title":"Ocular Immunology and Inflammation"},{"key":"10.1016\/j.bjid.2026.105946_bib0270","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/IAE.0b013e31822d3a34","article-title":"Factors determining visual outcome in endogenous Candida endophthalmitis","volume":"32","author":"Sallam","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.bjid.2026.105946_bib0271","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00006982-200509000-00010","article-title":"Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis","volume":"25","author":"Zhang","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.bjid.2026.105946_bib0272","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1469-0691.1997.tb00269.x","article-title":"Intravenous penetration of fluconazole during endophthalmitis","volume":"3","author":"Tod","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0273","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.43.12.2831","volume":"43","author":"Louie","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0274","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archopht.122.1.42","article-title":"Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in Humans","volume":"122","author":"Hariprasad","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.bjid.2026.105946_bib0275","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/AAC.46.12.3719-3723.2002","article-title":"Distribution of Intravenously Administered Lipid Formulations of Amphotericin B in a Rabbit Model","volume":"46","author":"Goldblum","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bjid.2026.105946_bib0276","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jiac.2021.04.020","article-title":"Intraocular penetration of liposomal amphotericin B after intravenous injection in inflamed human eyes","volume":"27","author":"Ando","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0277","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10384-015-0397-x","article-title":"Intravitreal liposomal amphotericin B for treatment of endogenous Candida endophthalmitis","volume":"59","author":"Bae","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.bjid.2026.105946_bib0278","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/jop.2023.0103","article-title":"The Effectiveness and Safety of Intravitreal Injections of Voriconazole in the Treatment of Fungal Endophthalmitis: A Systematic Review","volume":"40","author":"Xie","year":"2024","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.bjid.2026.105946_bib0279","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1128\/AAC.02300-12","article-title":"Intraocular Penetration of Intravenous Micafungin in Inflamed Human Eyes","volume":"57","author":"Mochizuki","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0280","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1128\/AAC.03324-14","article-title":"Pharmacokinetics and Safety of Intravitreal Caspofungin","volume":"58","author":"Shen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0281","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/09273948.2023.2168701","article-title":"Multiresistant Candida Endophthalmitis Treated with Intravitreal Caspofungin: A Case Report","volume":"32","author":"Garrido-Marin","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.bjid.2026.105946_bib0282","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diagmicrobio.2017.02.014","article-title":"No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins","volume":"88","author":"Mu\u00f1oz","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0283","first-page":"535","article-title":"Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes","volume":"87","author":"Pagano","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bjid.2026.105946_bib0284","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12879-019-4260-4","article-title":"Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0285","article-title":"Clinical characteristics and treatment response of chronic disseminated candidiasis in patients with hematological disorders","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.bjid.2026.105946_bib0286","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0891-5520(05)70128-8","article-title":"Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis","volume":"14","author":"Kontoyiannis","year":"2000","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bjid.2026.105946_bib0287","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1056\/NEJMoa061115","article-title":"An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU","volume":"355","author":"Pronovost","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0288","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/ice.2022.87","article-title":"Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update","volume":"43","author":"Buetti","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0289","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1062860614568647","article-title":"Sustaining Reductions in Central Line-Associated Bloodstream Infections in Michigan Intensive Care Units: A 10-Year Analysis","volume":"31","author":"Pronovost","year":"2016","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.bjid.2026.105946_bib0290","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"Huang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0291","doi-asserted-by":"crossref","DOI":"10.1080\/20002297.2023.2278937","article-title":"Sub-lethal concentrations of chlorhexidine inhibit Candida albicans growth by disrupting ROS and metal ion homeostasis","volume":"15","author":"Jiang","year":"2023","journal-title":"Journal of Oral Microbiology"},{"key":"10.1016\/j.bjid.2026.105946_bib0292","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1469-0691.2006.01369.x","article-title":"Antifungal activity of antimicrobial-impregnated devices","volume":"12","author":"Darouiche","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0293","doi-asserted-by":"crossref","first-page":"347","DOI":"10.12669\/pjms.342.14810","article-title":"Use of a chlorhexidine-impregnated dressing reduced catheter-related bloodstream infections caused by Gram-positive microorganisms","volume":"34","author":"Ergul","year":"2018","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.bjid.2026.105946_bib0294","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/ciab112","article-title":"An Infection Prevention Issue?","volume":"73","author":"Candidemia","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0295","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/cid\/ciab105","article-title":"Temporal Trends of Candidemia Incidence Rates and Potential Contributions of Infection Control Initiatives Over 18 Years Within the United States Veterans Health Administration System: A Joinpoint Time-Series Analysis","volume":"73","author":"Suzuki","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0296","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/502451","article-title":"Nosocomial Candidemia: An Ounce of Prevention Is Better Than a Pound of Cure","volume":"25","author":"Diekema","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0297","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21505594.2016.1226721","article-title":"Antifungal stewardship considerations for adults and pediatrics","volume":"8","author":"Hamdy","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.bjid.2026.105946_bib0298","first-page":"551","article-title":"Antimicrobial stewardship","volume":"28","author":"Lanckohr","year":"2022","journal-title":"Current Opin Crit Care"},{"key":"10.1016\/j.bjid.2026.105946_bib0300","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1017\/ice.2019.1","article-title":"Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities","volume":"40","author":"Rutala","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0301","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0302","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.bjid.2026.105946_bib0303","doi-asserted-by":"crossref","unstructured":"Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH. Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*: Critical Care Medicine. 2005;33:1928\u201335.","DOI":"10.1097\/01.CCM.0000178352.14703.49"},{"key":"10.1016\/j.bjid.2026.105946_bib0304","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41375-025-02586-7","article-title":"Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)","volume":"39","author":"Pagano","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.bjid.2026.105946_bib0305","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3026(22)00073-4","article-title":"Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association","volume":"9","author":"Stemler","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bjid.2026.105946_bib0306","first-page":"1215","article-title":"Infectious complications of targeted drugs and biotherapies in acute leukemia","volume":"36","author":"Maschmeyer","year":"2022"},{"key":"10.1016\/j.bjid.2026.105946_bib0307","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0308","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bjid.2026.105946_bib0309","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky286","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0310","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients","volume":"38","author":"Lehrnbecher","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bjid.2026.105946_bib0311","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0312","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/cid\/ciac230","article-title":"Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies","volume":"75","author":"Rausch","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0313","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0314","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jinf.2016.06.011","article-title":"Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients","volume":"73","author":"Park","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.09.017","article-title":"Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis","volume":"30","author":"Papanicolaou","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.bjid.2026.105946_bib0316","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2026.105946_bib0317","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bjid.2026.105946_bib0318","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bjid.2026.105946_bib0319","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/myc.13622","article-title":"A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections","volume":"66","author":"Kato","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0320","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/cid\/ciaa358","article-title":"Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study","volume":"72","author":"Bose","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0321","doi-asserted-by":"crossref","first-page":"ofaf163","DOI":"10.1093\/ofid\/ofaf163","article-title":"Incidence of Breakthrough Fungal Infections in Patients With Isavuconazole Prophylaxis: A Systematic Review and Meta-analysis","volume":"12","author":"Ishida","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0322","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s15010-025-02575-z","article-title":"Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC","volume":"53","author":"Salmanton-Garc\u00eda","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2026.105946_bib0323","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/ciu1128","article-title":"Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients","volume":"60","author":"Saliba","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0324","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/ajt.12963","article-title":"Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients","volume":"14","author":"Winston","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bjid.2026.105946_bib0325","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.transproceed.2012.06.013","article-title":"Role of liposomal amphotericin B prophylaxis after liver transplantation compared with fluconazole for high-risk patients. impact on infections and mortality within one year","volume":"44","author":"Perrella","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bjid.2026.105946_bib0326","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1432-2277.2002.tb00176.x","article-title":"Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study","volume":"15","author":"Biancofiore","year":"2002","journal-title":"Transpl Int"},{"key":"10.1016\/j.bjid.2026.105946_bib0327","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.transproceed.2005.10.043","article-title":"Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients","volume":"37","author":"Castroagud\u00edn","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bjid.2026.105946_bib0328","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1513\/AnnalsATS.202003-267OC","article-title":"The Impact of Antifungal Prophylaxis in Lung Transplant Recipients","volume":"18","author":"Pennington","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.bjid.2026.105946_bib0329","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.05219-11","article-title":"Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity","volume":"56","author":"Mitsani","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0330","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cid\/ciaa652","article-title":"Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients","volume":"73","author":"Samanta","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0331","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1111\/j.1600-6143.2009.02909.x","article-title":"Candida in Solid Organ Transplant Recipients","volume":"9","author":"Pappas","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bjid.2026.105946_bib0332","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000521354.57544.8a","article-title":"Low Incidence of Fungal Infections Following Intestinal Transplantation: a single center experience","volume":"101","author":"Patel","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.bjid.2026.105946_bib0333","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13623","article-title":"AST Infectious Disease Community of Practice Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bjid.2026.105946_bib0334","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/myc.13436","article-title":"Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods","volume":"65","author":"L\u00f3pez-Medrano","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0335","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/myc.12792","article-title":"Candidemia in children: Epidemiology, prevention and management","volume":"61","author":"Mantadakis","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0336","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-005-3452-1","article-title":"A 9-year Study Comparing Risk Factors and the Outcome of Paediatric and Adults with Nosocomial Candidaemia","volume":"160","author":"Pasqualotto","year":"2005","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0337","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015933","article-title":"Invasive candidiasis: Risk factor for mortality in a pediatric tertiary care hospital in south of Brazil","volume":"98","author":"Rodrigues","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bjid.2026.105946_bib0338","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/INF.0b013e3182737427","article-title":"Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates","volume":"31","author":"Steinbach","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0339","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000002530","article-title":"Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study","volume":"39","author":"Warris","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0340","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","article-title":"Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance","volume":"54","author":"da Silva","year":"2023","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0341","article-title":"Candida parapsilosis Candidaemia in a neonatal unit over 7 years: a case series study","volume":"2","author":"Miranda L das","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.bjid.2026.105946_bib0342","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0037-86822008000500005","article-title":"Candidemia neonatal, em hospital p\u00fablico do Mato Grosso do Sul","volume":"41","author":"Xavier","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bjid.2026.105946_bib0343","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/1806-93042021000200011","article-title":"Invasive candidiasis in a Brazilian neonatal intensive care unit","volume":"21","author":"Silva","year":"2021","journal-title":"Rev Bras Saude Mater Infant"},{"key":"10.1016\/j.bjid.2026.105946_bib0344","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1248082","article-title":"Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?","volume":"13","author":"Dassi","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bjid.2026.105946_bib0345","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae097","article-title":"Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates","volume":"62","author":"Rodrigues","year":"2024","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2026.105946_bib0346","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/myc.13106","article-title":"Candida spp bloodstream infections in a Latin American Pediatric Oncology Reference Center: Epidemiology and associated factors","volume":"63","author":"Paixao de Sousa da Silva","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0347","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jped.2016.05.007","article-title":"Risk factors for candidemia mortality in hospitalized children","volume":"93","author":"Motta","year":"2017","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.bjid.2026.105946_bib0348","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","article-title":"Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance","volume":"54","author":"da Silva","year":"2023","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0349","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/INF.0000000000003027","article-title":"Breakthrough Candidemia in Pediatric Patients With Cancer From a Brazilian Center","volume":"40","author":"Barrientos","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0350","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S0036-46652014000400006","article-title":"Fungemia caused by Candida species in a children\u2019s public hospital in the city of S\u00e3o Paulo, Brazil: study in the period 2007-2010","volume":"56","author":"Oliveira","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.bjid.2026.105946_bib0351","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015933","article-title":"Invasive candidiasis: Risk factor for mortality in a pediatric tertiary care hospital in south of Brazil","volume":"98","author":"Rodrigues","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bjid.2026.105946_bib0352","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae097","article-title":"Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates","volume":"62","author":"Rodrigues","year":"2024","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2026.105946_bib0353","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","article-title":"Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance","volume":"54","author":"da Silva","year":"2023","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0354","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11046-013-9616-5","article-title":"Candidemia by species of the Candida parapsilosis complex in children\u2019s hospital: prevalence, biofilm production and antifungal susceptibility","volume":"175","author":"Ruiz L da","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11046-015-9872-7","article-title":"Neonatal Candidemia Caused by Candida haemulonii: Case Report and Review of Literature","volume":"180","author":"Silva","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.bjid.2026.105946_bib0356","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jpids\/piaa038","article-title":"Bloodstream Infections With Candida auris Among Children in Colombia: Clinical Characteristics and Outcomes of 34 Cases","volume":"10","author":"Berrio","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.bjid.2026.105946_bib0357","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/jpc.15019","article-title":"Neonatal Candida auris infection: Management and prevention strategies - A single centre experience","volume":"56","author":"Chandramati","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.bjid.2026.105946_bib0358","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/516658","article-title":"Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place","volume":"28","author":"Pasqualotto","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0359","first-page":"326","article-title":"Candida parapsilosis bloodstream infections in a neonatal unit: high mortality rates and risk factors","volume":"88","author":"Miranda","year":"2012","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.bjid.2026.105946_bib0360","first-page":"281","volume":"56","author":"Groisman Sieben","year":"2024"},{"key":"10.1016\/j.bjid.2026.105946_bib0361","first-page":"386","article-title":"Invasive candidiasis in pediatric patients: clinical and microbiological findings","volume":"60","author":"Motta","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0362","first-page":"36","article-title":"Invasive candidiasis in Brazilian children: epidemiology and outcomes","volume":"23","author":"Rodrigues","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0363","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae097","article-title":"Invasive candidiasis in a pediatric tertiary hospital: Epidemiology, antifungal susceptibility, and mortality rates","volume":"62","author":"Rodrigues","year":"2024","journal-title":"Med Mycol"},{"key":"10.1016\/j.bjid.2026.105946_bib0364","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/INF.0000000000000039","article-title":"Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome","volume":"33","author":"Santolaya","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0365","first-page":"281","article-title":"Risk factors and mortality of candidemia in a children\u2019s public hospital in Sao Paulo","volume":"56","author":"Groisman Sieben","year":"2024","journal-title":"Brazil. Rev Argent Microbiol."},{"key":"10.1016\/j.bjid.2026.105946_bib0366","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","article-title":"Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance","volume":"54","author":"da Silva","year":"2023","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0367","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S0036-46652014000400006","article-title":"Fungemia caused by Candida species in a children\u2019s public hospital in the city of S\u00e3o Paulo, Brazil: study in the period 2007-2010","volume":"56","author":"Oliveira","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.bjid.2026.105946_bib0368","series-title":"Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Miller","year":"2024"},{"key":"10.1016\/j.bjid.2026.105946_bib0369","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/jof8121262","article-title":"Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data","volume":"8","author":"Ferreras-Antolin","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmi.2019.09.010","article-title":"Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis","volume":"26","author":"Cohen","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0371","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/JCM.00747-15","article-title":"\u03b2- d -Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","volume":"53","author":"Koltze","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2026.105946_bib0372","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cid\/ciab928","article-title":"Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents","volume":"75","author":"Fisher","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"18 Suppl 7","key":"10.1016\/j.bjid.2026.105946_bib0373","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0374","first-page":"158","article-title":"Recommendations for the management of candidemia in neonates in Latin America. Latin America Invasive Mycosis Network","volume":"30","author":"Santolaya","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.bjid.2026.105946_bib0375","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1080\/09273948.2025.2524013","article-title":"Endogenous Candida Endophthalmitis: An Update on Epidemiological, Pathogenetic, Clinical, and Therapeutic Aspects","volume":"33","author":"Gentile","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.bjid.2026.105946_bib0376","first-page":"1207","article-title":"Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates","volume":"11","author":"Baltogianni","year":"2024","journal-title":"Children (Basel)"},{"key":"10.1016\/j.bjid.2026.105946_bib0377","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70041","article-title":"The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed-EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates","volume":"68","author":"Bal","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0378","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40272-020-00379-2","article-title":"Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients","volume":"22","author":"Downes","year":"2020","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.bjid.2026.105946_bib0379","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/17425255.2020.1773793","article-title":"Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population","volume":"16","author":"Scott","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bjid.2026.105946_bib0380","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/INF.0000000000002317","article-title":"Management of Invasive Fungal Disease in Neonates and Children","volume":"38","author":"Ferreras-Antol\u00edn","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0381","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1128\/AAC.01172-16","article-title":"High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis","volume":"60","author":"Auriti","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0382","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13052-025-01852-9","article-title":"Micafungin versus Amphotericin B in treatment of invasive fungal infection in preterm neonates: a randomized control trial","volume":"51","author":"Ibrahim","year":"2025","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.bjid.2026.105946_bib0383","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/bcp.13628","article-title":"Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial","volume":"84","author":"Leroux","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bjid.2026.105946_bib0384","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jpids\/piae116","article-title":"Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network","volume":"13","author":"Bucayu","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.bjid.2026.105946_bib0385","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0386","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70041","article-title":"The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed-EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates","volume":"68","author":"Bal","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0387","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40272-022-00523-0","article-title":"Amphotericin B in Pediatrics: Analysis by Age Stratification Suggests a Greater Chance of Adverse Events from 13 Months of Age Onwards","volume":"24","author":"Cavassin","year":"2022","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.bjid.2026.105946_bib0388","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2024.01.011","article-title":"Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study","volume":"46","author":"Cavassin","year":"2024","journal-title":"Clin Ther"},{"key":"10.1016\/j.bjid.2026.105946_bib0389","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/524063","article-title":"The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates","volume":"197","author":"Hope","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bjid.2026.105946_bib0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/INF.0000000000002568","article-title":"Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia","volume":"39","author":"Roilides","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0391","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31560","article-title":"Systematic Review of the Presentation, Treatment, and Outcome of Chronic Disseminated Candidiasis in Children With Cancer or Following Hematopoietic Cell Transplant","volume":"72","author":"Eagling-Every","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bjid.2026.105946_bib0392","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/INF.0b013e31826f547c","article-title":"Ocular manifestations of candidemia in children","volume":"32","author":"Fierro","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"25","key":"10.1016\/j.bjid.2026.105946_bib0393","article-title":"Diagnosis and management of Candida endophthalmitis and chorioretinitis","volume":"S1198-743X","author":"Permpalung","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2026.105946_bib0394","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000002530","article-title":"Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study","volume":"39","author":"Warris","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2026.105946_bib0395","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jped.2023.11.005","article-title":"Epidemiological indicators and predictors of lethality associated with fungal infections in a NICU: a historical series","volume":"100","author":"Menezes R de","year":"2024","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.bjid.2026.105946_bib0396","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of Invasive Fungal Disease in Children","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.bjid.2026.105946_bib0397","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0378-3782(12)70014-2","article-title":"Getting to Zero\u201d: preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants","author":"Kaufman","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.bjid.2026.105946_bib0398","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3345\/cep.2019.01431","article-title":"Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis","volume":"64","author":"Robati Anaraki","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.bjid.2026.105946_bib0399","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3345\/cep.2019.01431","article-title":"Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis","volume":"64","author":"Robati Anaraki","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.bjid.2026.105946_bib0400","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOP.0b013e3282f79c48","article-title":"Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?","volume":"20","author":"Kaufman","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.bjid.2026.105946_bib0401","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70041","article-title":"The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed-EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates","volume":"68","author":"Bal","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2026.105946_bib0402","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/jac\/dky353","article-title":"Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants","volume":"73","author":"Autmizguine","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2026.105946_bib0403","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40506-022-00258-z","article-title":"Updates in the Pharmacologic Prophylaxis and Treatment of Invasive Candidiasis in the Pediatric and Neonatal Intensive Care Units: Updates in the Pharmacologic Prophylaxis","volume":"14","author":"Fly","year":"2022","journal-title":"Curr Treat Options Infect Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386702601336X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386702601336X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:19:49Z","timestamp":1789039189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S141386702601336X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":402,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S141386702601336X"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2026.105946","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2026.105946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"105946"}}